Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results

This study presents the preliminary results of a new otosurgical method in patients after canal wall down (CWD) surgery; it involves the implantation of the Bonebridge BCI 602 implant after obliteration of the mastoid cavity with S53P4 bioactive glass. The study involved eight adult patients who had...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Bartłomiej Król, Katarzyna Beata Cywka, Magdalena Beata Skarżyńska, Piotr Henryk Skarżyński
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-04-01
Saila:	Life
Gaiak:	S53P4 bioactive glass cholesteatoma mastoid obliteration otosurgery Bonebridge BCI 602 bone conduction implant
Sarrera elektronikoa:	https://www.mdpi.com/2075-1729/11/5/374
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!